List of Prepopik drug patents

Prepopik is owned by Ferring Pharms Inc.

Prepopik contains Citric Acid; Magnesium Oxide; Sodium Picosulfate.

Prepopik has a total of 2 drug patents out of which 0 drug patents have expired.

Prepopik was authorised for market use on 16 July, 2012.

Prepopik is available in for solution;oral dosage forms.

The generics of Prepopik are possible to be released after 10 October, 2028.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8450338 FERRING PHARMS INC Granular compositions of sodium picosulphate and potassium bicarbonate and uses thereof
Oct, 2028

(5 years from now)

US8481083 FERRING PHARMS INC Granular compositions of magnesium oxide and citric acid and uses thereof
Oct, 2028

(5 years from now)

Drugs and Companies using CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE ingredient

Market Authorisation Date: 16 July, 2012

Treatment: NA

Dosage: FOR SOLUTION;ORAL

How can I launch a generic of PREPOPIK before it's patent expiration?
More Information on Dosage

PREPOPIK family patents

4

United States

2

Korea, Republic of

2

China

2

European Union

1

Israel

1

South Africa

1

Denmark

IB

1

IB

1

Mexico

1

Australia

1

Saudi Arabia

1

Jordan

1

Russia

1

Lithuania

1

Slovenia

1

Hungary

1

Brazil

1

Croatia

1

Portugal

1

Spain

1

Poland

1

Taiwan, Province of China

1

United Kingdom

1

Japan

1

Canada

1

New Zealand

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in